Since the time you follow us on Croblanc, you are beginning to be used to hear about the Youtube channel Bloomberg Television, and its viral videos that are always talked about on the web, and even beyond! And so we decided to share with you today this latest content that might spark your interest.
As usual when the Youtube channel Bloomberg Television posts new content on the internet, you can find it on our site. To watch the latest video called "State and Local Governments Grapple With Cost of Ozempic", it's just above!
The video is doing a very good start since it was uploaded on the Youtube channel of Bloomberg Television and it could well end up in trend if the scores remain at these levels. However, we should not get too excited and wait a few days to see if this good start is confirmed with a buzz on the duration.
Internet users can sometimes encounter problems with a video, or simply want to transmit information following an error in the editing for example. First solution to contact the author of this video is on Youtube: Try to find his email address in "About". If you don't get an answer, you can try again to contact him but on another platform. Twitter seems to be a pretty easy way to contact a Youtuber about one of his contents.
You now have all the information about the video State and Local Governments Grapple With Cost of Ozempic, we hope you like it and that you found it interesting. Have you already watched the whole video? Don't forget to check our site for other content related to Bloomberg Television, we have a lot of it available and new videos are coming very soon, trust us!
And here it is already finished, we will see you very soon on Croblanc for a new article. Kisses, kisses, kisses!
For your information, you can find below the description of the video State and Local Governments Grapple With Cost of Ozempic published by the Youtube channel Bloomberg Television:
Expensive drugs to treat diabetes and obesity are threatening to drain the health-care budgets of state and local governments. State health plans and Medicaid offices are seeing big bills for Ozempic, its sister drug Wegovy and similar medications. Simone Foxman reports.
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en